WhichRecall
Class IIReported 2025-08-13

Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31

Recalled by Alembic Pharmaceuticals Limited

Reason for Recall

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

Advertisement
Recall Number
D-0566-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-07-25
Reported
2025-08-13
Distribution
Nationwide in the USA.
Code Info
Lot: 2305015142, Exp. Date: 9/30/2025
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement